Johnson and Johnson Update
Johnson and Johnson Stock and Shareholder News Updates
Johnson and Johnson Stock Update: Johnson and Johnson Shareholders To Receive Dividend Despite Company’s Ongoing Lawsuits Over Talc, Ethicon Mesh, DePuy Hips
March 5, 2019
Author: Daniel Gala
Despite the company and several of its wholly-owned subsidiaries continuing to be embroiled in serious products liability litigation brought by tens of thousands of plaintiffs in countries around the globe, Johnson & Johnson shareholders are to receive a quarterly dividend payable March 12, 2019, according to a company press release.
On January 2, Johnson & Johnson announced that “its Board of Directors had declared a cash dividend for the first quarter of 2019 of $0.90 per share of the company’s common stock. The dividend is payable on March 12, 2019 to shareholders of record at the close of business on February 26, 2019.”
“Today, as the world’s largest and most broadly-based health care company, we are committed to using our reach and size for good,” Johnson & Johnson’s press release reads. “We are blending our heart, science and ingenuity to profoundly change the trajectory of health for humanity.”
Here is quick rundown of just some of the products liability claims facing Johnson & Johnson and its subsidiaries, according to the company’s most recent filing with the US Securities and Exchange Commission (SEC);
Johnson and Johnson Product Liability Claims
Does this sound like the kind of company that should be giving out cash dividends to its shareholders, or should Johnson & Johnson’s Board of Directors focus more resolving existing claims and developing safer products in the future?
At least the brass at Johnson & Johnson are not coy about showing where their true priorities lie.
Johnson & Johnson News Release. (2 January 2019). Johnson & Johnson Announces Quarterly Dividend for First Quarter 2019
Johnson & Johnson Corporation. (20 February 2019). Form 10-K for 12 months ended Dec. 30, 2018. Notes to Financial Statements. Commitments and Contingencies Disclosure. Legal Proceedings. Product Liability. United States Securities and Exchange Commission (SEC)
Legal Disclaimer: The information in this article is not intended to be used as medical information or diagnosis. The sources of the information presented in the article have been researched and are linked within the article. Please seek out medical advice from a licensed medical professional if you are experiencing a problem with any of the drugs or devices mentioned in this article.
About The Law Firm
About TheLawFirm.com (TLF)
TheLawFirm.com is a group of award winning attorneys, paralegals and associates from the legal profession who’s main goal is to educate and represent their clients with the utmost expertise, respect and trust.
We also work closely with a large group of experts from the medical profession so we can draw upon their expertise, in order to present as much accurate information relating to various mass tort and personal injury lawsuits as we can.